Leptin:Adiponectin Ratio and Metabolic Syndrome in the General Japanese Population
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Circulating leptin:adiponectin ratio (L:A) is a potential surrogate marker for cardiometabolic diseases; however, the relationship of the L:A with the occurrence of metabolic syndrome (MetS) has not yet been fully explored in the general Japanese population. Methods: We enrolled 678 Japanese subjects (208 men and 470 women, mean age: 58.8±14.4 [SD] yr; mean body mass index: 23.6±3.3 kg/m2) in this study, and determined their MetS status by using the National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) recommendations with minor modifications for the Japanese population. Biochemical markers such as leptin and adiponectin present in blood were measured. The statistical analyses performed were gender-based. Results: The L:A in subjects with MetS was significantly higher than that in subjects without MetS, regardless of gender. The L:A also showed a significant and gradual increase corresponding to the increase in the number of components of MetS present in both the genders (trend P<0.01). The cut-off level of the L:A to detect MetS was 0.59 (sensitivity: 0.72, specificity: 0.70) in men and 1.04 (sensitivity: 0.72, specificity: 0.69) in women. Conclusions: These results suggest that the L:A can serve as a clinically useful marker for detecting MetS characteristics in the general Japanese population. The clinical application of this laboratory index for detecting MetS should be assessed in future studies.
Abstract
Background: Circulating leptin:adiponectin ratio (L:A) is a potential surrogate marker for cardiometabolic diseases; however, the relationship of the L:A with the occurrence of metabolic syndrome (MetS) has not yet been fully explored in the general Japanese population. Methods: We enrolled 678 Japanese subjects (208 men and 470 women, mean age: 58.8±14.4 [SD] yr; mean body mass index: 23.6±3.3 kg/m2) in this study, and determined their MetS status by using the National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) recommendations with minor modifications for the Japanese population. Biochemical markers such as leptin and adiponectin present in blood were measured. The statistical analyses performed were gender-based. Results: The L:A in subjects with MetS was significantly higher than that in subjects without MetS, regardless of gender. The L:A also showed a significant and gradual increase corresponding to the increase in the number of components of MetS present in both the genders (trend P<0.01). The cut-off level of the L:A to detect MetS was 0.59 (sensitivity: 0.72, specificity: 0.70) in men and 1.04 (sensitivity: 0.72, specificity: 0.69) in women. Conclusions: These results suggest that the L:A can serve as a clinically useful marker for detecting MetS characteristics in the general Japanese population. The clinical application of this laboratory index for detecting MetS should be assessed in future studies.
참고문헌 (18)
- Klein BE, "Components of the metabolic syndro-me and risk of cardiovascular disease and diabetes in beaver dam", Diabetes Care, 25, pp.1790~1794 (2002)
- Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men", JAMA, 288, pp.2709~2716 (2002)
- McNeill AM, "The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study", Diabetes Care, 28, pp.385~390 (2005)
- Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)
- Park HS, "Prevalen-ce and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001", Diabetes Obes Metab, 9, pp.50~58 (2007)
- Satoh N, "Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients", Diabetes Care, 27, pp.2488~2490 (2004)
- Kotani K, "Leptin : adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes : relationship of the index to carotid intima-media thickness", Diabetologia, 48, pp.2684~2686 (2005)
- Inoue M, "Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes", Metabolism, 54, pp.281~286 (2005)
- Inoue M, "Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia", Metabolism, 55, pp.1248~1254 (2006)
- Taniguchi A, "Pathogenic factors responsible for glucose intolerance in patients with NIDDM", 41, pp.1540~1546 (1992)
- Examination Committee of Criteria for ‘Obesity Disease’ in Japan, "Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan", Circ J, 66, pp.987~992 (2002)
- Kawamoto R, "Metabo-lic syndrome and carotid atherosclerosis: role of elevated blood pressure", J Atheroscler Thromb, 12, pp.268~275 (2005)
- Schisterman EF, "Youden index and the optimal threshold for markers with mass at zero", Stat Med, 27, pp.297~315 (2008)
- Beltowski J, "Leptin and atherosclerosis", Atherosclerosis, 189, pp.47~60 (2006)
- Oh DK, "Adiponectin in health and disease", Diabetes Obes Metab, 9, pp.282~289 (2007)
- Tarnopolsky MA, "Sex differences in carbohydrate metabolism", Curr Opin Clin Nutr Metab Care, 4, pp.521~526 (2001)
- Williams CM, "Lipid metabolism in women", Proc Nutr Soc, pp.153~160 (2004)
- Arai H, "Prevalence of metabolic syndrome in the general Japanese population in 2000", J Atheroscler Thromb, 13, pp.202~208 (2006)